US General Surgical Devices Market Segmentation 2018 to 2023 | Topmost Players: B. BRAUN MELSUNGEN AG, BOSTON SCIENTIFIC CORPORATION, CADENCE, INTEGER HOLDINGS CORPORATION, MAQUET HOLDING B.V. & CO. KG., MEDTRONIC

The US general surgical devices market is expected to register a CAGR of 6.5% during the forecast period, 2018 to 2023. Increasing demand for technologically advanced surgical devices, favorable reimbursement policies, and growing investment from the private sector in healthcare are the factors augmenting the growth of the US general surgical devices market.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16960
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Favorable Health Insurance Policies
The reimbursement system in the United States consists of public/private and third-party payment system. For instance, in 2016, 53 million people over 65 years of age were covered by the federal Medicare program. According to the Census Bureau’s report on health insurance coverage, the uninsured rate dropped from 10.4% to 9.1% in 2014. The growing aging population, well-established health insurance coverage system from the public and private, and drop in uninsured rate are likely to drive the growth of the US general surgeries market. Additionally, the presence of key players, technological advancements, easy availability of surgical devices in hospitals, and growing awareness regarding minimally invasive surgeries are the factors driving the growth of US general surgical devices market.

Key Developments in the Market
• March 2016: W. L. Gore & Associates, Inc. (Gore) launched GOREu00ae SYNECOR Biomaterial, a unique hybrid device for hernia repair.
• January 2017: Ethicon Endo-Surgery, Inc. acquired Megadyne Medical Products, Inc., a private company which manufactures electrosurgical tools used in operating rooms worldwide.

Major Players:
B. BRAUN MELSUNGEN AG, BOSTON SCIENTIFIC CORPORATION, , CADENCE INC. INTEGER HOLDINGS CORPORATION, MAQUET HOLDING B.V. & CO. KG., MEDTRONIC, CONMED CORPORATION, OLYMPUS CORPORATIONS, STRYKER CORPORATION, AND JOHNSON & JOHNSON, amongst others.

Get Quality Discount @ https://marketprognosis.com/discount-request/16960
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Stringent Regulatory Environment
The US regulatory process is time-consuming as compared to other European countries. For instance, the devices that need communication with FDA regarding a clinical study for the low- to moderate- risk device before making a regulatory submission, the premarket process for such devices takes an average of 31 months for clearance. In contrast, an average of seven months is required in Europe for clearance of the same devices. Thus, a stringent regulatory process and a cut down in the reimbursement scenario are also likely to impede the growth of the US general surgical devices market.

Orthopedic to Dominate the Market
The general surgical devices market is segmented by product, applications, and geography. By application, it is segmented into obstetrics and gynecology, plastic and reconstructive surgeries, urology, cardiology, orthopedic, and others. The orthopedic segment dominates the general surgical devices market owing to the rise in a number o

Browse Report @ https://marketprognosis.com/enquiry/16960
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.